[HTML][HTML] Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
S Hu, N Logan, J Puenpa, N Wanlapakorn… - Vaccine, 2022 - Elsevier
Background Although the number of measles cases declined globally in response to anti-
measles immunisation campaigns, measles has re-emerged. A review of current vaccination …
measles immunisation campaigns, measles has re-emerged. A review of current vaccination …
Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose
S Carazo Perez, G De Serres, A Bureau… - Clinical Infectious …, 2017 - academic.oup.com
Background The effect of age at first dose on the immunogenicity of a 2-dose pediatric
schedule of measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) …
schedule of measles-mumps-rubella (MMR) or measles-mumps-rubella-varicella (MMRV) …
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination
N Bautista-López, BJ Ward, E Mills, D McCormick… - Vaccine, 2000 - Elsevier
The correlates of long-term protection from measles infection are poorly understood. We
followed the development of measles-specific antibody and lymphoproliferative (LP) …
followed the development of measles-specific antibody and lymphoproliferative (LP) …
Waning of measles maternal antibody in infants in measles elimination settings–a systematic literature review
FM Guerra, NS Crowcroft, L Friedman, SL Deeks… - Vaccine, 2018 - Elsevier
Introduction Most infants are born with immunity to measles through maternal antibodies
transferred in pregnancy, which decay over time. However, in measles elimination settings …
transferred in pregnancy, which decay over time. However, in measles elimination settings …
[HTML][HTML] Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study
Characterizing the long-term kinetics of maternally derived and vaccine-induced measles
immunity is critical for informing measles immunization strategies moving forward. Based on …
immunity is critical for informing measles immunization strategies moving forward. Based on …
[PDF][PDF] Immunogenicity and reactogenicity of indigenously produced MMR vaccine
I Bhargava, BC Chhaparwal, MA Phadke… - Indian …, 1995 - indianpediatrics.net
IMMUNOGENICITY AND REACTOGENICITY OF INDIGENOUSLY PRODUCED MMR VACCINE
Page 1 IMMUNOGENICITY AND REACTOGENICITY OF INDIGENOUSLY PRODUCED MMR …
Page 1 IMMUNOGENICITY AND REACTOGENICITY OF INDIGENOUSLY PRODUCED MMR …
[HTML][HTML] Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 …
DM Vittrup, A Jensen, JK Sørensen, AC Zimakoff… - …, 2024 - thelancet.com
Background Measles is a highly contagious viral disease. Vaccinated mothers transfer fewer
antibodies during pregnancy, resulting in shortened infant immunity. Earlier primary …
antibodies during pregnancy, resulting in shortened infant immunity. Earlier primary …
[HTML][HTML] Additional Evidence on serological correlates of protection against Measles: an observational cohort study among once vaccinated children exposed to …
T Woudenberg, R van Binnendijk, I Veldhuijzen… - Vaccines, 2019 - mdpi.com
To assess correlates of protection against measles and against subclinical measles virus
(MV) infection, we recruited once-vaccinated children from geographic regions associated …
(MV) infection, we recruited once-vaccinated children from geographic regions associated …
A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine
IH Haralambieva, IG Ovsyannikova, M O'Byrne… - Vaccine, 2011 - Elsevier
The measurement of measles-specific neutralizing antibodies, directed against the surface
measles virus hemagglutinin and fusion proteins, is considered the gold standard in …
measles virus hemagglutinin and fusion proteins, is considered the gold standard in …
Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII® at 15 months of age and antibody levels at 27 months of age
MM Carson, DW Spady, JA Beeler, MP Krezolek… - Vaccine, 2005 - Elsevier
The worldwide elimination of measles is an important target. In developed countries, to
control measles outbreaks, immunization from 6 months of age is recommended. In this …
control measles outbreaks, immunization from 6 months of age is recommended. In this …